Psychiatric Disorders With Prolonged Infertility

August 1, 2023 updated by: Ayman S Dawood, MD, Tanta University

Psychiatric Disorders Among Egyptian Women With Prolonged Infertility With or Without Invitro Fertilization /Intracytoplasmic Spem Injection Failure

Psychiatric disorders in women with prolonged infertility with or without IVF/ICSI failure will be included then a questionnaire will be applied plus psychiatric examinatins

Study Overview

Detailed Description

All patients will be recruited from both psychiatry and obstetrics and gynecology departments. Referred cases from gynecologists and Assisted reproductive technologies centers were also included.

Inclusion criteria:

Infertile couples Infertility >= 5 years invitro fertilization /intracytoplasmic spem injection failure for group 1 and not included for group 2

Study Type

Observational

Enrollment (Actual)

324

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tanta, Egypt
        • Reham Amer

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

All infertile women with prolonged infertility with or without history of IVF/ICSI failure

Description

Inclusion Criteria:

  • Infertile women
  • prolonged infertility ≥ 5 years
  • Failed invitro fertilization /intracytoplasmic spem injection for group 1
  • not bearing any children
  • accepting to share in the study.

Exclusion Criteria:

  • patients with diagnosed psychiatric or neurologic disorders
  • patients with diabetes mellitus or any anatomical defects in genital tract
  • patients who didn't complete their questionnaires.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
IVF/ICSI failure
These patients had prolonged infertility with one or more failure of IVF/ICSI cycles
All included patients will be exposed to questionnaires and psychiatric diagnostic tests
Other Names:
  • Psychiatric diagnostic tests
Prolonged infertility only
These patients had prolonged infertility without any trials of IVF/ICSI cycles
All included patients will be exposed to questionnaires and psychiatric diagnostic tests
Other Names:
  • Psychiatric diagnostic tests

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence and types of psychiatric disorders among prolonged infertility couples
Time Frame: 6 months
Incidence and most common types of psychiatric disorders
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Ayman Dawood, MD, Lecturer at Tanta University
  • Principal Investigator: Reham Amer, MD, Lecturer at Tanta University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2018

Primary Completion (Actual)

December 31, 2022

Study Completion (Actual)

December 31, 2022

Study Registration Dates

First Submitted

June 14, 2018

First Submitted That Met QC Criteria

June 14, 2018

First Posted (Actual)

June 26, 2018

Study Record Updates

Last Update Posted (Actual)

August 3, 2023

Last Update Submitted That Met QC Criteria

August 1, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Ayman

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data is secret as privacy and security of data is a must

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychiatric Disorder

Clinical Trials on Questionnaire

3
Subscribe